Exploring Creades AB Investor Profile: Who’s Buying and Why?

Who's buying Creades AB (0QI9.L) and why? A striking ownership map shows Biovestor Aktiebolag holding a commanding 59% stake-equal to 80,147,040 shares-while individual investors collectively own 25.7% or 34,867,288 shares, and institutional investors account for 14.6% (19,760,833 shares); alongside these major positions, key institutional holders include Spiltan Fonder AB at 2.28% (3,092,710 shares), Handelsbanken Asset Management at 2.22% (3,018,767 shares), Avanza Fonder AB at 2.19% (2,976,239 shares), Carnegie Särskilda Pensionsstiftelse II at 1.83% (2,485,990 shares) and AMF Fonder AB at 1.05% (1,425,000 shares), a mix that the OECD notes mirrors advanced-market patterns where institutions dominate but retail participation remains meaningful; these concentrated and varied stakes-dominated by a private company yet buoyed by sizeable retail and measured institutional positions-shape governance levers, potential strategic alignments, and the market dynamics that follow, so read on to see how these numbers translate into influence, risk and opportunity for different types of investors

Creades AB (0QI9.L) - Who Invests in Creades AB (0QI9.L) and Why?

• Private companies (59.0% - 80,147,040 shares): strategic investors like Biovestor Aktiebolag maintain controlling influence to steer long-term investments, align portfolio strategies, and secure board representation.
• Individual investors (25.7% - 34,867,288 shares): attracted by access to an actively managed investment vehicle, potential long-term value creation, dividend prospects and the ability to participate in a concentrated equity story.
• Institutional investors (14.6% - 19,760,833 shares): provide validation from professional managers, add oversight, demand transparency and liquidity, and often invest for risk‑adjusted returns and portfolio diversification.

• Governance is likely influenced by strategic private holders who can shape capital allocation and board composition.
• Retail ownership adds an element of public scrutiny and vote unpredictability, potentially amplifying or constraining management moves.
• Institutional ownership, though smaller, supplies analytical oversight and supports market credibility and liquidity.

Creades AB (0QI9.L) Institutional Ownership and Major Shareholders of Creades AB (0QI9.L)

Institutional ownership in Creades AB (0QI9.L) is concentrated, with Biovestor Aktiebolag holding a controlling stake. Below is a snapshot of the largest registered shareholders as of December 31, 2024, plus the implied total share base and free float.

Key takeaways on investor composition and motivations:

• Control: Biovestor Aktiebolag's 59% stake confers de facto control, shaping strategic direction and board composition.
• Long-term stewardship: Large direct owner suggests a patient, concentrated investment horizon focused on capital preservation and selective capital allocation.
• Institutional breadth: Several asset managers (Spiltan, Handelsbanken AM, Avanza, AMF, Carnegie) hold modest single-digit stakes, indicating cautious diversification into Creades for exposure to its investment portfolio and governance structure.
• Free float: Roughly 31.4% free float supports tradability while limiting takeover risk and dilutive trading influence.

Investor behavior drivers (why they buy):

• Access to diversified investment holdings via a listed investment company structure without direct operational exposure.
• Governance and value-play: Investors seeking influence or alignment with Biovestor's long-term strategy.
• Yield/total-return potential from underlying assets and possible buybacks/dividend policy decisions influenced by majority holder.
• Portfolio allocation: Institutional fund mandates targeting Swedish/EUR-region equities or alternative indexed exposures often include listed investment companies like Creades.

For more on Creades' background, ownership evolution and how the company operates, see: Creades AB: History, Ownership, Mission, How It Works & Makes Money

Creades AB (0QI9.L) - Key Investors and Their Impact on Creades AB (0QI9.L)

• Biovestor Aktiebolag - 59.00%: dominant controlling stake, able to determine board appointments, strategic M&A direction and dividend policy; effectively sets corporate strategy given simple-majority voting thresholds.
• Spiltan Fonder AB - 2.28%: modest but active shareholder likely to engage on valuation, capital deployment and performance-linked governance matters.
• Handelsbanken Asset Management - 2.22%: conservative institutional holder emphasizing long-term stability, risk controls and adherence to established governance practices.
• Avanza Fonder AB - 2.19%: retail-oriented fund allocator with a cautious, low-turnover approach; focuses on steady returns and downside protection.
• Carnegie Särskilda Pensionsstiftelse II - 1.83%: significant institutional pension fund holding that can influence governance topics through coordinated engagement with other institutions.
• AMF Fonder AB - 1.05%: modest institutional presence prioritizing diversification and measured risk exposure.

• Aggregate institutional ownership (listed above): 68.57% - indicates a mix of controlling ownership plus diversified institutional backing that supports stability but may limit minority shareholder influence.
• Voting dynamics: Biovestor's 59% stake exceeds simple-majority thresholds, enabling unilateral approval of ordinary resolutions and strong leverage in extraordinary decisions unless supermajority rules apply.
• Governance implications: With large controlling ownership, board independence metrics typically hinge on the company's formal independence policies and minority protections rather than raw ownership dispersion.
• Liquidity & free float: Given the concentration, available free float is materially reduced, which can increase share price volatility on low-volume trades and affect index inclusion calculations.

Creades AB (0QI9.L) - Market Impact and Investor Sentiment

• Approximate ownership breakdown: Biovestor Aktiebolag (majority/concentrated holder) ~29%.
• Institutional ownership (combined, including Spiltan Fonder AB, Handelsbanken Asset Management, and others) ~42%.
• Private companies and individual investors combined ~29%, creating diverse reaction profiles to corporate moves.

• The substantial ownership by private companies and individual investors may lead to more volatile short-term price swings as diverse investor reactions surface following news, earnings, or portfolio rebalances.
• The significant institutional investment indicates institutional confidence in Creades AB's financial stability and growth prospects, which supports lower-cost capital and steadier long-term demand for shares.
• Concentration of ownership at Biovestor Aktiebolag means strategic decisions (board nominations, M&A stance, dividend policy) could reflect Biovestor's priorities and materially affect minority shareholders.
• Specific institutions such as Spiltan Fonder AB and Handelsbanken Asset Management show cautious positioning - modest stake sizes and measured changes - suggesting conservative market sentiment and emphasis on downside protection.
• The diverse investor base creates a balanced perception: institutions provide credibility and stability, while private/retail investors supply liquidity and episodic trading activity.